Intervention
QS21
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 8 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
8 shownVaccine Therapy and QS21 in Treating Patients With Metastatic Breast CancerNCT00470574 · 2007-03-20
COMPLETEDVaccine Therapy Plus QS21 in Treating Patients With Prostate CancerNCT00036933 · 2002-03-01
COMPLETEDVaccine Therapy in Treating Patients at High Risk for Breast Cancer RecurrenceNCT00030823 · 2001-03-01
COMPLETEDMultivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate CancerNCT00579423 · 2000-11-01
COMPLETEDVaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate CancerNCT00004929 · 1999-09-01
COMPLETEDVaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial TherapyNCT00004249 · 1998-08-01
COMPLETEDVaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate CancerNCT00003819 · 1998-06-01
COMPLETEDVaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of DiseaseNCT00003357 · 1998-01-01
COMPLETEDCommon conditions
Leading sponsors
Trial status mix
COMPLETED8
Phase mix
PHASE14
NA2
PHASE22
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.